In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Percutaneous Systems Inc.

Latest From Percutaneous Systems Inc.

Percutaneous Systems Inc. (PercSys)

Stone disease is among the most painful and prevalent of urologic disorders, affecting more than 5% of the US population. The most common intervention for kidney and ureteral stones involves manipulation, irrigation and fragmentation through an endoscope. However, such procedures may cause the stone itself or stone fragments to migrate within the urinary tract. Current devices to reduce migration are difficult to place and remove, and they do not adequately conform to the ureter. These products also do not provide a fluid-tight seal. In contrast, the PercSys Accordion stone management device from Percutaneous Systems (PercSys) effectively eliminates stone migration and facilitates fragment removal. The microcatheter system forms an occlusion in the ureter to prevent stone migration, has been shown to increase fragmentation efficiency, and has demonstrated its ability to sweep multiple fragments.
Medical Device

Start-Up Previews (05/2009)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, "Medical Dermatology Gets Under VCs' Skin," features profiles of Garnet Biotherapeutics, Medimetriks and Topica Pharmaceuticals. Plus these Start-Ups Across Health Care: Carolus Therapeutics, Forma Therapeutics, NovaLign Orthopaedics, OmegaGenesis and PercSys.
See All

Company Information

  • Industry
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Gynecological, Urological
  • Alias(es)
  • PercSys
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Percutaneous Systems Inc.
  • Senior Management
  • Gary Curtis, Pres. & CEO
  • Contact Info
  • Percutaneous Systems Inc.
    Phone: (650) 493-4200
    3260 Hillview Ave.
    Ste. 100
    Palo Alto, CA 94304